Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | -77M | 258M | 258M | 263M | 259M |
| Gross Profit | -253M | 78M | 66M | 97M | 102M |
| Operating Income | -716K | 11M | 2M | -6M | -3M |
| EBITDA | -716K | 11M | 1M | 0 | -3M |
| Net Income | -1M | 6M | 2M | -6M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$11.25
-4.26% today
1Y Change
-4.26%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pekin Life Insurance Company (PKIN) is a Financial Services stock with a market cap of $200.00M and listed on OTC. The stock last traded around $11.25 and down 4.3% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -130.0%, EPS growth of -121.0%, a dividend yield of 0.0%. What stands out right now is revenue -130.0%, EPS -121.0%, free cash flow -1260.9% with operating margin 0.9% and ROIC -0.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PKIN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PKIN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PKIN Max Drawdown
-12.77%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PKIN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$259.1M
-1.6% YoY
FY Net Income
-$5.3M
+5.6% YoY
Free Cash Flow
$38.2M
+0.5% YoY
Revenue Growth
-130.0%
EPS Growth
-121.0%
Gross Margin
327.5%
Net Margin
1.8%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | -77M | 258M | 258M | 263M | 259M |
| Gross Profit | -253M | 78M | 66M | 97M | 102M |
| Operating Income | -716K | 11M | 2M | -6M | -3M |
| EBITDA | -716K | 11M | 1M | 0 | -3M |
| Net Income | -1M | 6M | 2M | -6M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 13M | 12M | 4M | 10M | 5M |
| Total Assets | 1.7B | 1.7B | 1.6B | 1.6B | 1.6B |
| Total Liabilities | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B |
| Shareholder Equity | 129M | 116M | 115M | 122M | 122M |
| Total Debt | 5M | 5M | 4M | 0 | 0 |
| Net Debt | -8M | -7M | 243K | -10M | -5M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
38M
+0.5% YoY
Capital Expenditures
0
Free Cash Flow
38M
+0.5% YoY
Key ratios
Gross Margin
327.5%
Operating Margin
0.9%
Net Margin
1.8%
ROE
-1.1%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.